Quantcast
Home > Quotes > WVE

Wave Life Sciences Ltd. Ordinary Shares (WVE) Quote & Summary Data

WVE 
$39.73
*  
0.37
0.92%
Get WVE Alerts
*Delayed - data as of Mar. 26, 2019 12:29 ET  -  Find a broker to begin trading WVE now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    WVE Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 39.62 / $ 39.75
Today's High / Low
$ 40.63 / $ 38.70
Share Volume
69,476
50 Day Avg. Daily Volume
414,772
Previous Close
$ 40.10
52 Week High / Low
$ 56 / $ 32.25
Market Cap
1,358,452,371
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
69,476
50 Day Avg. Daily Volume:
414,772

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -5.06

Trading Range

The current last sale of $39.73 is 23.19% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 40.63 $ 56
 Low: $ 38.70 $ 32.25

Company Description (as filed with the SEC)

We are a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Using PRISM, our proprietary discovery and drug development platform that enables the precise design, optimization and production of novel stereopure oligonucleotides, we aspire to develop best in class medicines across multiple therapeutic modalities. Nucleic acid therapeutics, including oligonucleotides, are a growing and innovative class of drugs comprised of a sequence of nucleotides that are linked together by a backbone of chemical bonds. We are initially developing oligonucleotides that target the ribonucleic acid ("RNA") to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. RNA is a critical molecule that can adopt complex three-dimensional structures and affect various cellular functions.  ... More ...  



Risk Grade

Where does WVE fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 40.35
Open Date:
Mar. 26, 2019
Close Price:
$ 40.10
Close Date:
Mar. 25, 2019


Consensus Recommendation

Analyst Info